Rimexolone
From Wikipedia, the free encyclopedia
Systematic (IUPAC) name | |
---|---|
(8S,9S,10R,11S,13S,14S,16R,17S)-11-Hydroxy-10,13,16,17-tetramethyl-17-propanoyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
|
|
Clinical data | |
AHFS/Drugs.com | Monograph |
MedlinePlus | a606003 |
Pregnancy category |
|
Routes of administration |
Eye drops |
Identifiers | |
CAS Number | 49697-38-3 |
ATC code | H02AB12 (WHO) S01BA13 (WHO) |
PubChem | CID 5311412 |
IUPHAR/BPS | 7099 |
DrugBank | DB00896 |
ChemSpider | 4470902 |
UNII | O7M2E4264D |
KEGG | D05729 |
ChEMBL | CHEMBL1200617 |
Chemical data | |
Formula | C24H34O3 |
Molar mass | 370.525 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
|
(what is this?) (verify) |
Rimexolone is a glucocorticoid steroid used to treat inflammation in the eye.[1] It is marketed as a 1% eye drop suspension under the trade name Vexol by Alcon Laboratories.[2]
References[edit]
- ^ Kavuncu S, Horoz H, Ardagil A, Erbil HH (August 2008). "Rimexolone 1% versus prednisolone acetate in preventing early postoperative inflammation after cataract surgery". Int Ophthalmol. 28 (4): 281–5. doi:10.1007/s10792-007-9131-0. PMID 17762913.
- ^ Haberfeld, H, ed. (2015). Austria-Codex (in German). Vienna: Österreichischer Apothekerverlag.
This hormonal preparation article is a stub. You can help Wikipedia by expanding it. |